ClinicalTrials.Veeva

Menu

Essential Fatty Acids in Adult ADHD (OCEAN-GER)

U

Universität des Saarlandes

Status and phase

Completed
Phase 3

Conditions

Adult Attention Deficit Hyperactivity Disorder

Treatments

Dietary Supplement: Essential fatty acids

Study type

Interventional

Funder types

Other

Identifiers

NCT01798381
OCEAN-GER

Details and patient eligibility

About

The aim of this project is to investigate the effect of a dietary supplementation with essential fatty acids in adults on cognitive functions related to attention and impulse control in the general population and in individuals with a diagnosis of attention deficit hyperactivity disorder (ADHD).

Enrollment

100 patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • DSM-IV ADHD

Exclusion criteria

  • any acute psychiatric disorder

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

100 participants in 2 patient groups, including a placebo group

Essential fatty acids
Active Comparator group
Description:
Omega-3
Treatment:
Dietary Supplement: Essential fatty acids
Placebo
Placebo Comparator group
Description:
Placebo tablet
Treatment:
Dietary Supplement: Essential fatty acids

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems